Home » Products » Anti Cancer Medicine » Iclusig Ponatinib Tablet

Iclusig Ponatinib Tablet

Iclusig Ponatinib Tablet
Send Inquiry
Product Code : asp
Brand Name : Iclusig Ponatinib Tablet
Price And Quantity
  • Minimum Order Quantity
  • 10 Box
  • Price
  • 1 USD ($)
Product Specifications
  • Drug Type
  • Other Types
  • Ingredients
  • Ponatinib
  • Physical Form
  • Tablets
  • Dosage
  • Tablets
  • Quantity
  • 10 Boxes
Product Description

ICLUSIG (ponatinib) is a prescription medicine used to treat adults who have:

  • chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) who cannot receive any other tyrosine kinase inhibitor (TKI) medicines
  • a specific type of abnormal gene (T315I-positive) chronic phase, accelerated phase, or blast phase CML, or T315I-positive Ph+ ALL

ICLUSIG is not for use to treat people with newly diagnosed chronic phase CML.

It is not known if ICLUSIG is safe and effective in children less than 18 years of age.


Take your prescribed dose of ICLUSIG once a day, at about the same time every day. You can take your daily dose with or without food. Please consult with your healthcare provider if you have any questions on how to take ICLUSIG. For a more complete list, reference the Patient Medication Guide.


45 mg

The recommended starting dose of ICLUSIG is 45 mg once daily. This dose comes in tablets stamped AP4.

30 mg

15 mg

If you have hepatic impairment, the recommended starting dose of ICLUSIG is 30 mg once daily. If you take certain medications, your doctor may prescribe a 30 mg dose of ICLUSIG. If you experience certain side effects, your doctor may prescribe you a lower dose of ICLUSIG: Either 30 mg or 15 mg daily. Side effects leading to dose reductions may include:

  • decreased bone marrow activity (low blood cell counts)
  • liver problems
  • inflammation of the pancreas and elevation of lipase (pancreatitis)
  • other adverse reactions you may experience

Patients prescribed a lower dose will receive their ICLUSIG in 15 mg tablets stamped A5.


Daily dose reminders:
  • Take ICLUSIG exactly as your healthcare provider tells you to take it.
  • Swallow ICLUSIG tablets whole. Do not crush or dissolve ICLUSIG tablets.
  • You may take ICLUSIG with or without food.
  • If you miss a dose of ICLUSIG, take your next dose at your regular time. Do not take 2 doses at the same time to make up for a missed dose.
  • If you take too much ICLUSIG, call your healthcare provider or go to the nearest hospital emergency room right away.
What should I tell my healthcare provider before taking ICLUSIG? If you:
  • have a history of blood clots in your blood vessels (arteries or veins)
  • have heart problems, including heart failure, irregular heartbeats, and QT prolongation
  • have diabetes
  • have a history of high cholesterol
  • have liver problems
  • have had inflammation of your pancreas (pancreatitis)
  • have high blood pressure
  • are pregnant or plan to become pregnant. ICLUSIG can harm your unborn baby. You should not become pregnant while taking ICLUSIG. Tell your healthcare provider right away if you become pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed. It is not known if ICLUSIG passes into your breast milk. You and your healthcare provider should decide if you will take ICLUSIG or breastfeed. You should not do both.
  • have bleeding problems
  • plan to have any surgical procedures
  • are lactose (milk sugar) intolerant. ICLUSIG tablets contain lactose.
  • drink grapefruit juice
  • have any other medical conditions

Tell your healthcare provider about all the medicines you take, including prescription medicines and over-the-counter medicines, vitamins, and herbal supplements. ICLUSIG and other medicines may affect each other causing side effects.

Additional Information:

  • Delivery Time: 10 days
Trade Information
  • FOB Port
  • mumbai
  • Payment Terms
  • Others, Western Union
  • Delivery Time
  • 10 Days
  • Sample Policy
  • Contact us for information regarding our sample policy
  • Packaging Details
  • 30 Tablets
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia


ASPAR PHARMACEUTICALS All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.